Biotech: Page 31
-
Retrieved from Rare Disease.org.Q&A
For the CEO of Travere, running a rare disease company is personal
To kick off Rare Disease month, we interview the CEO of Travere Therapeutics
By Kim Ribbink • Feb. 1, 2022 -
Q&A
Foghorn's CEO on why collaborations are key to unlocking precision medicine
With a major development deal under his belt, Adrian Gottschalk is helping the company advance its innovative platform.
By Robin Robinson • Jan. 28, 2022 -
Explore the Trendline➔
Stock via Getty ImagesTrendlineTech for Clinical Trials
Companies that utilize these emerging technologies wisely are likely to find an edge in the increasingly competitive drug development arena.
By PharmaVoice staff -
Profile
Taking the leap and not having all the answers: How incoming CEO Kate Haviland plans to lead Blueprint
For Haviland, success in biotech is about more than drug development.
By Alexandra Pecci • Jan. 28, 2022 -
Opinion
Biopharma's R&D leaders on how technology can accelerate drug development
How emerging digital tools are providing enhanced clinical insights and improved trial results.
By Taren Grom • Jan. 27, 2022 -
How AI is helping pharma solve some of its COVID problems
With the pressure still on pharma to innovate quickly and go digital, the use-cases for AI are increasing in stride.
By Meagan Parrish • Jan. 25, 2022 -
Profile
One man's quest to boost the patient's role in clinical trials
How a personal diagnosis inspired Craig Lipset to transform patient involvement in medical research.
By Robin Robinson • Jan. 24, 2022 -
Retrieved from Google image.Opinion
Leaders predict improving patient engagement will lead to growth opportunities
Why patient engagement is key to successful business growth.
By Taren Grom • Jan. 24, 2022 -
Retrieved from Google image.Profile
Evofem CEO Saundra Pelletier aims to level the playing field between men's and women's health
Evofem CEO and PharmaVoice100, Saundra Pelletier, discusses funding challenges for women's health.
By Alexandra Pecci • Jan. 23, 2022 -
Profile
Vaxxinity looks to pioneer the next revolution in pharma
With a one-of-a-kind platform and novel candidates for major indications, Vaxxinity wants to disrupt the industry’s paradigm of success.
By Meagan Parrish • Jan. 14, 2022 -
Retrieved from Google image.Opinion
Pharma execs reveal the industry's most pressing issues
Several market factors — including COVID — are driving changes and trends in the industry.
By Taren Grom • Jan. 14, 2022 -
Pharma M&A stagnated in 2021 — here's what could help it rebound
There are plenty of reasons pharma could get its M&A groove back in 2022.
By Meagan Parrish • Jan. 13, 2022 -
Welcome to the new PharmaVoice
A similar mission, a new format, and our plans for PharmaVoice's next chapter.
By Davide Savenije • Jan. 13, 2022 -
Biote CEO breaks down barriers in women's health
Women’s health is coming into sharper focus in 2022, but getting funding is still difficult.
By Robin Robinson • Jan. 11, 2022 -
[photo]. Retrieved from Ovid Therapeutics.Q&A
Ovid's CEO shares his vision for rare disease developments
Jeremy Levin, chairman and CEO of Ovid Therapeutics discusses the keys to success in rare disease innovation.
By Kim Ribbink • Jan. 10, 2022 -
Q&A
How the executive VP of HR at Incyte is tackling pharma's hiring woes
In an industry undergoing rapid growth, the increasing job opening rates and limited talent pool are taking on a new level of importance.
By Meagan Parrish • Jan. 10, 2022 -
Australian firefighters raise funds for ALS research
Funding for rare disease clinical trials can be a challenge, but in Australia, firefighters gear up to raise money for ALS.
By Kim Ribbink • Jan. 5, 2022 -
[photo]. Retrieved from Google image.
Rare disease innovation in 2022
More companies are targeting gene therapies for rare disease treatments.
By Kim Ribbink • Jan. 5, 2022 -
Profile
PharmaVoice 100 Who's on the List – By Category
Who’s on the List — 2021 Indexed by Category Commanders & Chiefs Dr. Sam Agresta Foghorn Therapeutics Alisha Alaimo Biogen Shideh Bina Insigniam Dr. Norbert Bischofberger Kronos Bio Dr. James Kyle Bryan IQVIA Biotech Victor Bultó Novartis Pharmaceuticals Dr. Tony ...
By PharmaVoice Team • Aug. 1, 2021 -
Profile
Entrepreneurs
These visionary leaders recognized an opportunity to fill an industry need and are successfully leading their companies to new heights. Do you have CLAS? (Culturally and Linguistically Appropriate Strategies) Igniting change by… Having courageous conversations about race, ethnicity...
By PharmaVoice Team • Aug. 1, 2021 -
Profile
Change Agents
These forward-thinking individuals are disrupting the status quo and setting the strategic direction for their companies to capitalize on the opportunities that will shape the future of the healthcare ecosystem. Put people first, the rest will follow Sparking innovation by… collabor...
By PharmaVoice Team • Aug. 1, 2021 -
2021 Red Jacket Honorees
Inspiring leaders for today and tomorrow Since launching the Red Jacket Award in 2014, PharmaVOICE has recognized 40 inspiring, innovative, collaborative, and transformative individuals who epitomize leadership for today and tomorrow. One of the criteria for being named a Red Jacket — our version...
By PharmaVoice Team • Aug. 1, 2021 -
Profile
Red Jacket Ahsan Awan
A man of many talents Sparking innovation by… creating a world that works for everyone Ahsan A. Awan Title: VP of Clinical Development Company: Genlantis Diagnostics Education: J.D., University of Oregon School of Law; M.S.Pharm., Pharmacy, Pharmacoeconomics, University of Florid...
By Ahsan Awan • Aug. 1, 2021 -
Profile
Red Jacket Jack Barrette
Giving a voice to patient advocates Sparking innovation by… powering human connections for a healthier world Jack Barrette Title: Chief Innovation Officer, Health Union (formerly Founder & CEO of WEGO Health) Company: Health Union Education: B.A., English Industry Awards: Ph...
By Jack Barrette • Aug. 1, 2021 -
Profile
Red Jacket Olivier Chateau
Redefining social health Blazing new trails by… innovating online communities Olivier Chateau Title: Co-Founder and CEO Company: Health Union Industry Awards: PharmaVOICE 100, 2018, 2009; EY Entrepreneur of the Year Award, 2020 Company Awards: Inc.’s Best Workplaces; Forbe...
By Olivier Chateau • Aug. 1, 2021 -
Profile
Red Jacket Laurie Cooke
A leader of leaders Blazing new trails by… advancing gender parity and equity Laurie Cooke, RPh Title: President and CEO Company: Healthcare Businesswomen’s Association Education: PG Dip, Software Engineering Management, University of Luton; Advanced Degree, Pharmacy, Unive...
By Laurie Cooke • Aug. 1, 2021